CNTB

Connect Biopharma Holdings Limited Ordinary Shares
CNTB

Overview Fund Activity

25 hedge funds and large institutions have $16.4M invested in Connect Biopharma Holdings Limited Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 10 closing their positions.

Holders
25
Holders Change
-4
Holders Change %
-13.79%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
12
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OCA
1
Octagon Capital Advisors
New York
$581K
2
CL
2
CSS LLC
Illinois
$50K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$107K
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$4K
5
SA
5
SRH Advisors
Kansas
$2K

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$0
2
IC
2
Ikarian Capital
Texas
$283K
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$1.65M
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
DCM
5
DAFNA Capital Management
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
26
Two Sigma Investments
New York
– -$24K -28,016 Closed
CPIG
27
Chicago Partners Investment Group
Illinois
– -$17K -20,651 Closed
VIA
28
Vident Investment Advisory
Georgia
– -$16K -18,062 Closed
VF
29
Virtu Financial
New York
– -$14K -16,658 Closed
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
– -$12K -13,750 Closed
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
– -$11K -13,110 Closed
Wells Fargo
32
Wells Fargo
California
– -$1K -1,000 Closed
1
2